SCHEMBL845478

SCHEMBL845478

COCC(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3ccc(N(C)C)cc3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.43
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
RHOC P08134 1/20 0.42
RHOA P61586 1/20 0.42
ROCK2 O75116 1/20 0.41
ALDH1A1 P00352 4/20 0.41
MAPK1 P28482 3/20 0.41
HTT P42858 1/20 0.41
GPR183 P32249 1/20 0.39
TSHR P16473 2/20 0.39
PABPC1 P11940 1/20 0.39
EP300 Q09472 2/20 0.39
CREBBP Q92793 2/20 0.39
PREP P48147 1/20 0.38
KCNH2 Q12809 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845229 0.91 RHOC (0.48) NPC1CYP2C9CYP2C19MAPTRHOC
SCHEMBL844961 0.89 RHOC (0.43) NPC1CYP2C9CYP2C19MAPTRHOC
SCHEMBL845206 0.88 CYP2C9 (0.52) NPC1CYP2C9CYP2C19ALDH1A1MAPK1
SCHEMBL845340 0.84 ALDH1A1 (0.43) NPC1CYP2C9CYP2C19MAPTRHOC
SCHEMBL845599 0.84 RHOC (0.43) NPC1CYP2C9CYP2C19RHOCRHOA
SCHEMBL845475 0.82 ROCK2 (0.44) NPC1CYP2C9CYP2C19RHOCRHOA
SCHEMBL844900 0.79 CYP2C9 (0.47) NPC1CYP2C9CYP2C19ALDH1A1MAPK1
SCHEMBL10119687 0.79 CYP2C9 (0.44) NPC1CYP2C9CYP2C19ALDH1A1MAPK1
SCHEMBL844902 0.77 ALDH1A1 (0.47) NPC1CYP2C9CYP2C19ALDH1A1MAPK1
SCHEMBL845300 0.77 CYP2C9 (0.54) CYP2C9CYP2C19MAPTRHOCRHOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed